-
1 Comment
Shenyang Xingqi Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 2.5% below its 200 day moving average.
From a valuation standpoint, the stock is 40.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.5.
Shenyang Xingqi Pharmaceutical Co., Ltd's total revenue rose by 46.5% to $233M since the same quarter in the previous year.
Its net income has increased by 68.3% to $38M since the same quarter in the previous year.
Finally, its free cash flow grew by 420.3% to $21M since the same quarter in the previous year.
Based on the above factors, Shenyang Xingqi Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100002DV1 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | 12B |
|---|---|
| Target Price | None |
| Dividend Yield | 1.4% |
| Beta | 0.48 |
| PE Ratio | 36.72 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic drug in the People's Republic of China. The company develops ophthalmic anti-infective drugs, other ophthalmic drugs, nonsteroidal anti-inflammatory drugs for ophthalmology, mydriatic and ciliary muscle paralytic drugs, ophthalmic anti-inflammatory/anti-infective compound drugs, dry eye products, miotic and anti-glaucoma drugs, and other drugs. It also develops products, such as Zirun, a Cyclosporine eye drops; Sugaojie, a calf blood deproteinized extract eye gel/eye drops; Diyou eye gel; Difei eye drops; and Ziyang, a vitamin A palmitate eye gel. In addition, the company is involved in Ophthalmology hospital services; sale of medicines, health foods, and medical devices; operation of telecommunications business; and optometry and glasses services. The company was founded in 1977 and is headquartered in Shenyang, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300573.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
